Share
- Release Date: 27/08/13 18:10
- Summary: RELINT: ABA: Ongoing Disclosure Notice - P.Dunphy
- Price Sensitive: No
- Download Document 1.73KB
ABA
27/08/2013 16:10
RELINT
REL: 1610 HRS Abano Healthcare Group Limited
RELINT: ABA: Ongoing Disclosure Notice - P.Dunphy
Ongoing Disclosure Notice
Disclosure of Directors and Officers Relevant Interests
Section 19T(2), Securities Markets Act 1988
A Details of director or officer
Name of director or officer of public issuer: Philippa Jane DUNPHY
Name of public issuer: Abano Healthcare Group Limited
Name of related body corporate (if applicable): N/A
Position held in public issuer: Director
B Securities in public issuer or related body corporate to which this
disclosure relates
Number, class, and type of securities: 61 ordinary shares (total holding of
3,053 ordinary shares after the transaction)
C Nature of relevant interest and name of registered holder
Nature of relevant interest in those securities: Registered holder &
beneficial owner
Name of registered holder of those securities Philippa Jane Dunphy
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition: 23 August 2013
Consideration paid for acquisition: $381.44
If the relevant interest was disposed of--
Date of disposal: N/A
Consideration received for disposal: N/A
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition or disposal took place: Issue of shares pursuant to
participation in the Dividend Reinvestment Plan for the 2013 final dividend
E Total number of transactions this notice relates to: 1 transaction
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 15 May 2013
G Signature
Signature of director or officer:
Date of signature: 27 August 2013
End CA:00240257 For:ABA Type:RELINT Time:2013-08-27 16:10:43
